The amygdala, a relay station for switching on and off pain

T. Rouwette, P. Vanelderen, E. W. Roubos, Tamas Kozicz, K. Vissers

Research output: Contribution to journalReview article

37 Citations (Scopus)

Abstract

Neuropathic pain is strongly associated with mood disorders like anxiety and depression. Corticotropin-releasing factor (CRF) plays a prominent role in these disorders as it is up-regulated in limbic structures such as the amygdala, upon experimentally induced neuropathy. This review discusses recent literature on the role of CRF in pain processing and highlights the amygdala as a potential hot spot in supraspinal descending pain control. Many studies have demonstrated analgesic effects of CRF following local and systemic administration, but more recently also hyperalgesic effects were shown upon endogenous amygdalar CRF increase or by blocking the CRF type 1 receptor (CRFR1). On the basis of the reviewed literature, we postulate a central mechanism for pain control in which the amygdala plays a critical role by switching on and off chronic pain. In this mechanism, upon pain stimuli, CRFR1 in the amygdala is activated by CRF to induce hyperalgesia. When the activated CRFR1 is internalized (pain initiation), it triggers the translocation of the cytoplasmic CRF type 2 receptor (CRFR2) to the plasma membrane. Here, CRFR2 can be recruited by either high (pharmacological) concentrations of CRF or by endogenous CRFR2 ligands, the urocortins, leading to analgesia (pain termination). This on-off switching of pain is completed by redistribution of the CRF receptors to their initial activity state.We furthermore propose that in neuropathic pain, this mechanism is dysregulated and causes a state of permanent hyperalgesia, and present an integrative (patho)physiological model for the way disturbed CRF receptor signalling in the amygdala could initiate neuropathic pain.

Original languageEnglish (US)
Pages (from-to)782-792
Number of pages11
JournalEuropean Journal of Pain (United Kingdom)
Volume16
Issue number6
DOIs
StatePublished - Jul 1 2012
Externally publishedYes

Fingerprint

Amygdala
Corticotropin-Releasing Hormone
Pain
Neuralgia
Corticotropin-Releasing Hormone Receptors
Hyperalgesia
Urocortins
Mood Disorders
Chronic Pain
Analgesia
Analgesics
Anxiety
Cell Membrane
Pharmacology
Depression
Ligands

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The amygdala, a relay station for switching on and off pain. / Rouwette, T.; Vanelderen, P.; Roubos, E. W.; Kozicz, Tamas; Vissers, K.

In: European Journal of Pain (United Kingdom), Vol. 16, No. 6, 01.07.2012, p. 782-792.

Research output: Contribution to journalReview article

Rouwette, T. ; Vanelderen, P. ; Roubos, E. W. ; Kozicz, Tamas ; Vissers, K. / The amygdala, a relay station for switching on and off pain. In: European Journal of Pain (United Kingdom). 2012 ; Vol. 16, No. 6. pp. 782-792.
@article{341be9e769e54d25bacfc6cf31d824be,
title = "The amygdala, a relay station for switching on and off pain",
abstract = "Neuropathic pain is strongly associated with mood disorders like anxiety and depression. Corticotropin-releasing factor (CRF) plays a prominent role in these disorders as it is up-regulated in limbic structures such as the amygdala, upon experimentally induced neuropathy. This review discusses recent literature on the role of CRF in pain processing and highlights the amygdala as a potential hot spot in supraspinal descending pain control. Many studies have demonstrated analgesic effects of CRF following local and systemic administration, but more recently also hyperalgesic effects were shown upon endogenous amygdalar CRF increase or by blocking the CRF type 1 receptor (CRFR1). On the basis of the reviewed literature, we postulate a central mechanism for pain control in which the amygdala plays a critical role by switching on and off chronic pain. In this mechanism, upon pain stimuli, CRFR1 in the amygdala is activated by CRF to induce hyperalgesia. When the activated CRFR1 is internalized (pain initiation), it triggers the translocation of the cytoplasmic CRF type 2 receptor (CRFR2) to the plasma membrane. Here, CRFR2 can be recruited by either high (pharmacological) concentrations of CRF or by endogenous CRFR2 ligands, the urocortins, leading to analgesia (pain termination). This on-off switching of pain is completed by redistribution of the CRF receptors to their initial activity state.We furthermore propose that in neuropathic pain, this mechanism is dysregulated and causes a state of permanent hyperalgesia, and present an integrative (patho)physiological model for the way disturbed CRF receptor signalling in the amygdala could initiate neuropathic pain.",
author = "T. Rouwette and P. Vanelderen and Roubos, {E. W.} and Tamas Kozicz and K. Vissers",
year = "2012",
month = "7",
day = "1",
doi = "10.1002/j.1532-2149.2011.00071.x",
language = "English (US)",
volume = "16",
pages = "782--792",
journal = "European journal of pain (London, England)",
issn = "1090-3801",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - The amygdala, a relay station for switching on and off pain

AU - Rouwette, T.

AU - Vanelderen, P.

AU - Roubos, E. W.

AU - Kozicz, Tamas

AU - Vissers, K.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Neuropathic pain is strongly associated with mood disorders like anxiety and depression. Corticotropin-releasing factor (CRF) plays a prominent role in these disorders as it is up-regulated in limbic structures such as the amygdala, upon experimentally induced neuropathy. This review discusses recent literature on the role of CRF in pain processing and highlights the amygdala as a potential hot spot in supraspinal descending pain control. Many studies have demonstrated analgesic effects of CRF following local and systemic administration, but more recently also hyperalgesic effects were shown upon endogenous amygdalar CRF increase or by blocking the CRF type 1 receptor (CRFR1). On the basis of the reviewed literature, we postulate a central mechanism for pain control in which the amygdala plays a critical role by switching on and off chronic pain. In this mechanism, upon pain stimuli, CRFR1 in the amygdala is activated by CRF to induce hyperalgesia. When the activated CRFR1 is internalized (pain initiation), it triggers the translocation of the cytoplasmic CRF type 2 receptor (CRFR2) to the plasma membrane. Here, CRFR2 can be recruited by either high (pharmacological) concentrations of CRF or by endogenous CRFR2 ligands, the urocortins, leading to analgesia (pain termination). This on-off switching of pain is completed by redistribution of the CRF receptors to their initial activity state.We furthermore propose that in neuropathic pain, this mechanism is dysregulated and causes a state of permanent hyperalgesia, and present an integrative (patho)physiological model for the way disturbed CRF receptor signalling in the amygdala could initiate neuropathic pain.

AB - Neuropathic pain is strongly associated with mood disorders like anxiety and depression. Corticotropin-releasing factor (CRF) plays a prominent role in these disorders as it is up-regulated in limbic structures such as the amygdala, upon experimentally induced neuropathy. This review discusses recent literature on the role of CRF in pain processing and highlights the amygdala as a potential hot spot in supraspinal descending pain control. Many studies have demonstrated analgesic effects of CRF following local and systemic administration, but more recently also hyperalgesic effects were shown upon endogenous amygdalar CRF increase or by blocking the CRF type 1 receptor (CRFR1). On the basis of the reviewed literature, we postulate a central mechanism for pain control in which the amygdala plays a critical role by switching on and off chronic pain. In this mechanism, upon pain stimuli, CRFR1 in the amygdala is activated by CRF to induce hyperalgesia. When the activated CRFR1 is internalized (pain initiation), it triggers the translocation of the cytoplasmic CRF type 2 receptor (CRFR2) to the plasma membrane. Here, CRFR2 can be recruited by either high (pharmacological) concentrations of CRF or by endogenous CRFR2 ligands, the urocortins, leading to analgesia (pain termination). This on-off switching of pain is completed by redistribution of the CRF receptors to their initial activity state.We furthermore propose that in neuropathic pain, this mechanism is dysregulated and causes a state of permanent hyperalgesia, and present an integrative (patho)physiological model for the way disturbed CRF receptor signalling in the amygdala could initiate neuropathic pain.

UR - http://www.scopus.com/inward/record.url?scp=84867710985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867710985&partnerID=8YFLogxK

U2 - 10.1002/j.1532-2149.2011.00071.x

DO - 10.1002/j.1532-2149.2011.00071.x

M3 - Review article

VL - 16

SP - 782

EP - 792

JO - European journal of pain (London, England)

JF - European journal of pain (London, England)

SN - 1090-3801

IS - 6

ER -